Tocilizumab, an anti-IL-6 receptor antibody, to treat COVID-19-related respiratory failure: a case report

被引：249

作者：

Michot, J. -M. ^{[1
]}

Albiges, L. ^{[2
]}

Chaput, N. ^{[3
]}

Saada, V. ^{[4
]}

Pommeret, F. ^{[2
]}

Griscelli, F. ^{[4
]}

Balleyguier, C. ^{[5
]}

Besse, B. ^{[2
]}

Marabelle, A. ^{[1
]}

Netzer, F. ^{[6
]}

Merad, M. ^{[2
]}

Robert, C. ^{[2
]}

Barlesi, F. ^{[2
]}

Gachot, B. ^{[7
]}

Stoclin, A. ^{[7
]}

机构：

[1] Univ Paris Saclay, Dept Therapeut Innovat & Early Testing, Gustave Roussy, Villejuif, France

[2] Univ Paris Saclay, Med Oncol, Gustave Roussy, Villejuif, France

[3] CNRS, INSERM, Mol Anal Modelisat & Imagerie Malad Canc, Gustave Roussy,Lab Immunomonitoring Oncol, Villejuif, France

[4] Univ Paris Saclay, Gustave Roussy, Dept Biol, Villejuif, France

[5] Univ Paris Saclay, Gustave Roussy, Dept Med Imaging, Villejuif, France

[6] Univ Paris Saclay, Gustave Roussy, Dept Pharm, Villejuif, France

[7] Univ Paris Saclay, Gustave Roussy, Intens Care Dept, Villejuif, France

来源：

ANNALS OF ONCOLOGY | 2020年 / 31卷 / 07期

关键词：

D O I：

10.1016/j.annonc.2020.03.300

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：961 / 964

页数：4

共 10 条

[1]

Cao B, 2020, NEW ENGL J MED, V382, P1787, DOI [10.1056/NEJMoa2001282, 10.1056/NEJMc2008043]

[2] Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology [J].

Channappanavar, Rudragouda ;

Perlman, Stanley .

SEMINARS IN IMMUNOPATHOLOGY, 2017, 39 (05) :529-539

[3] Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study [J].

Chen, Nanshan ;

Zhou, Min ;

Dong, Xuan ;

Qu, Jieming ;

Gong, Fengyun ;

Han, Yang ;

Qiu, Yang ;

Wang, Jingli ;

Liu, Ying ;

Wei, Yuan ;

Xia, Jia'an ;

Yu, Ting ;

Zhang, Xinxin ;

Zhang, Li .

LANCET, 2020, 395 (10223) :507-513

[4]

Conti P, 2020, J BIOL REG HOMEOS AG, V34, P327, DOI 10.23812/CONTI-E

[5] Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial [J].

Gabay, Cem ;

Emery, Paul ;

van Vollenhoven, Ronald ;

Dikranian, Ara ;

Alten, Rieke ;

Pavelka, Karel ;

Klearman, Micki ;

Musselman, David ;

Agarwal, Sunil ;

Green, Jennifer ;

Kavanaugh, Arthur .

LANCET, 2013, 381 (9877) :1541-1550

[6]

Huang CL, 2020, LANCET, V395, P497, DOI [10.1016/S0140-6736(20)30183-5, 10.1016/S0140-6736(20)30211-7]

[7] Current concepts in the diagnosis and management of cytokine release syndrome [J].

Lee, Daniel W. ;

Gardner, Rebecca ;

Porter, David L. ;

Louis, Chrystal U. ;

Ahmed, Nabil ;

Jensen, Michael ;

Grupp, Stephan A. ;

Mackall, Crystal L. .

BLOOD, 2014, 124 (02) :188-195

[8] A new era for the treatment of inflammatory autoimmune diseases by interleukin-6 blockade strategy [J].

Tanaka, Toshio ;

Narazaki, Masashi ;

Ogata, Atsushi ;

Kishimoto, Tadamitsu .

SEMINARS IN IMMUNOLOGY, 2014, 26 (01) :88-96

[9] Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome [J].

Wong, CK ;

Lam, CWK ;

Wu, AKL ;

Ip, WK ;

Lee, NLS ;

Chan, IHS ;

Lit, LCW ;

Hui, DSC ;

Chan, MHM ;

Chung, SSC ;

Sung, JJY .

CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2004, 136 (01) :95-103

[10] Pathological findings of COVID-19 associated with acute respiratory distress syndrome [J].

Xu, Zhe ;

Shi, Lei ;

Wang, Yijin ;

Zhang, Jiyuan ;

Huang, Lei ;

Zhang, Chao ;

Liu, Shuhong ;

Zhao, Peng ;

Liu, Hongxia ;

Zhu, Li ;

Tai, Yanhong ;

Bai, Chongqing ;

Gao, Tingting ;

Song, Jinwen ;

Xia, Peng ;

Dong, Jinghui ;

Zhao, Jingmin ;

Wang, Fu-Sheng .

LANCET RESPIRATORY MEDICINE, 2020, 8 (04) :420-422

← 1 →